Research Article
[Retracted] circSOX4 Enhances Hepatocellular Carcinoma Progression via miR-218-5p/YY1 Signaling
Table 1
circSOX4 is increased in hepatocellular carcinoma.
| | Clinicopathological characteristics | Total | circSOX4 high level () | circSOX4 low level () | | value |
| | Gender | | | | | | | Male | 21 | 11 | 10 | 0.082 | 0.774 | | Female | 29 | 14 | 15 | | Age | | | | | | | ≤50 | 30 | 16 | 14 | 0.333 | 0.564 | | >50 | 20 | 9 | 11 | | Tumor size | | | | | | | | 27 | 12 | 15 | 0.725 | 0.395 | | | 23 | 13 | 10 | | Differentiation | | | | | | | High | 22 | 15 | 7 | 6.253 | 0.044 | | Moderate | 13 | 6 | 7 | | Poor | 15 | 4 | 11 | | Lymph node metastasis | | | | | | | Positive | 28 | 18 | 10 | 5.195 | 0.023 | | Negative | 22 | 7 | 15 | | TMN stages | | | | | | | | 24 | 8 | 16 | 5.128 | 0.024 | | | 26 | 17 | 9 | | HBV infection | | | | 0.321 | 0.571 | | Positive | 24 | 11 | 13 | | Negative | 26 | 14 | 12 | | Distant metastasis | | | | 5.195 | 0.023 | | M0 | 22 | 7 | 15 | | M1 | 28 | 18 | 10 |
|
|